⏳ Early Bird Ends In....
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Life Science Executive Partnering
Congress Sept 16-17, Forums Sept 15, 2025BCEC, Boston, USAKey Sessions
Jessica Federer
Investing in Biotech Breakthroughs: A VC Outlook
Angelini Ventures
Ruchira Glaser
Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare
Novartis
Lei Meng
Series A Secured, What's Next? Scaling Your Biotech
Bain Capital Life Sciences
Scott DeWire
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
Boehringer Ingelheim
Jason Hafler
Funding Biotech Innovation: The CVC Perspective
Sanofi Ventures
Mike Patten
New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025
Harbour BioMed
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)
search
Streams
Formats
8:00am - 9:00am
Registration & Breakfast
Showing 3 of 3 Streams
Biotech Leaders Morning Keynote Plenary
Medtech Leaders
Pharmatech Leaders
9:00am - 9:05am
LSX Welcome Address
9:05am - 9:55am
Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare
- Ruchira Glaser - Chief Medical Officer & Global Head of Clinical Development, Novartis
- Maha Radhakrishnan - Executive Partner, Sofinnova Investments
- Kiran Reddy - Managing Director, Blackstone Life Sciences
- Mary Schaheen - President, Prevail Partners
- Geeta Vemuri - Founder & Managing Partner, Agent Capital
9:55am - 10:30am
Fireside Chat: Opportunities and Challenges Ahead for Biopharma – Looking to 2026
9:00am - 9:10am
LSX Welcome Address
9:10am - 9:50am
Mapping the Medtech Exit Landscape: Strategies for Companies in a Changing Market
- Wayne Jarvis - Senior Director BD and Portfolio Strategy, Coloplast
9:50am - 10:30am
Medtech’s Next Big Thing: Where the Big Players Are Placing Their Focus
- Ryan McGuinness - General Manager, Commercial, Triple Ring Technologies
- Denise Clarke - Director, Strategy & Business Development, Philips Healthcare
9:00am - 9:10am
LSX Welcome Address
9:10am - 9:50am
AI & Pharma – Operationalising AI for Enhanced Patient and Commercial Benefits
- Emre Ozcan - SVP, Global Head of Digital Health & Devices, Merck
- Alexandra Gonçalves - VP, Head of Digital Health, BMS
- Morten Sogaard - SVP & Head, Astellas Innovation Lab
9:50am - 10:30am
Ask the Experts: Pharma 4.0 – Emerging Digital Technologies Shaping the Future of Pharma
- Jim Parshall - Executive Director, Drug Delivery R&D, Eli Lilly
- Supriya Bakshi - Head of Digital Health & Experience Innovation, Alexion
- Ameya Phadke - Patients Non-Pharma Solutions Leader, Chiesi
- Ravi Kaushik - VP, Global Head of Device & Digital Innovation & Product Strategy, Takeda
10:30am - 11:00am
Morning Break
Showing 5 of 5 Streams
Biotech Leaders Capital Markets & Investment
Biotech Leaders Partnerships & Deal Making
Market Opportunities & Commercialisation
Medtech Leaders
Pharmatech Leaders
11:00am - 11:50am
Investing in Biotech Breakthroughs: A VC Outlook
- Jessica Federer - Board Member, Angelini Ventures
- Hal Paz - Operating Partner, Khosla Ventures
- Soyoung Park - General Partner, 1004 Venture Partners
- Sally Wang Liang - Managing Partner, Xpanse Venture
11:50am - 12:40pm
Funding Biotech Innovation: The CVC Perspective
- Jason Hafler - Managing Director, Sanofi Ventures
- Marian Nakada - VP, Venture Investments, JJDC
- Fei Shen - Managing Director, Boehringer Ingelheim Venture Fund
- Cookie Yu - Investment Director, Samsung Ventures
11:00am - 11:50am
Partnerships That Pay Off: The Blueprint for Biopharma Success
- Jon Kiburz - VP Transactions, R&D Business Development, GSK
- Laura Collins - Senior Director, Transactions, Business Development, AstraZeneca
- Clare Fisher - SVP BD and M&A, BeiGene
- Anu Connor - VP, Head of Oncology External Innovation, IPSEN
11:50am - 12:40pm
Licensing Goldmines: Turning Intellectual Property into Biotech Success
- Carla Bauer - Director, Oncology S&E, BD&L, Merck
- Swarna Balasubramanian - Associate Director, S&E, BD&L, AstraZeneca
- Alex Goddard - Director, McQuade Center for Strategic R&D, Otsuka Pharmaceuticals
11:00am - 11:50am
From Molecules to Millions: How to Build a Biotech Powerhouse
- Scott Saywell - EVP, Corporate Development, Coherus BioSciences
- Paul Bresge - CEO, Ray Therapeutics
- Joe Goldberg - National Life Sciences Industry Consulting Leader, RSM US LLP
- Milenko Cicmil - CEO & Co-Founder, Tasca Therapeutics
- Rich Yang - CEO, Biolinq
11:50am - 12:40pm
Unlocking AI’s Full Potential to Transform Drug Discovery & Development
- Julie Frearson - SVP Chief Scientific Officer, Charles River Laboratories
11:00am - 11:40am
Walking the Walk: The Future of Women’s Health and Effective Company Scaling
- Tracy Macneal - CEO, Materna Medical
- Amelia Degenkolb - CEO, Novocuff, Inc.
- Anula Jayasuriya - Co-Founder, Kidron Capital
12:00pm - 12:40pm
Roadmap to Reimbursement: Strategies for Reimbursement Success Amidst a Changing CMS Landscape
- Cody Simmons - CEO, DermaSensor
- Kristen Hedstrom - VP, Market Access & Professional Education, Integra LifeSciences
- John Pracyk - SVP, Chief Medical Safety Officer - Global, Olympus Corporation
11:00am - 11:50am
Pharma Tech Collaborations & Partnerships with Life Science Startups
- Abhay Kakde - Director, Global Strategy & Operations, AstraZeneca
- Krys Zaluski - Director, External Growth, Biogen
- Uli Stilz - Corporate Vice President, R&ED External Innovation Partners, External & Exploratory Innovation, Novo Nordisk
11:50am - 12:40pm
Disruptive Dollars: Investing in the Future of Pharma Innovation
- Naomi Fried - CEO & Founder, PharmStars
- Cris De Luca - Partner, Digital, Sanofi Ventures
- Ester Caffarel-Salvador - Director of Strategic Innovation, Chiesi USA
- John Pavletic - Executive Director, Lilly Ventures
12:40pm - 1:40pm
Lunch Break
Showing 5 of 5 Streams
Biotech Leaders Capital Markets & Investment
Biotech Leaders Partnerships & Deal Making
Market Opportunities & Commercialisation
Medtech Leaders
Pharmatech Leaders
1:40pm - 2:30pm
Beyond the Pitch: Landing Early-Stage VC Funding
- Mahesh Narayanan - Managing Partner, Neuvation Ventures
- Salar Roshan - Operating Partner, 3E Bioventures Capital
- Giles Hamilton - Operating Partner, New Growth Advisors
2:30pm - 3:20pm
Series A Secured, What's Next? Scaling Your Biotech
- Lei Meng - Managing Director, Life Sciences, Bain Capital Life Sciences
- Evan Caplan - Principal, OrbiMed
- Jamil Bag - Partner, SV Health Investors
- John Boyce - Managing Director and Co-Founder, TigerGene
1:40pm - 2:30pm
Collaborating for Innovation: The Role of Research Partnerships in Biotech
- Simone Mori - Program Leader - External Research Venture, Moderna
- Alison Fenney - Executive Director, Strategic Partnerships and Business Operations, Regeneron Genetics Center
- Alicia Zhou - CEO, Cancer Research Institute
- Peng Leong - CBO and Therapeutic Area Head, Brain Aging, BioAge
- Alfred Slanetz - Chairman, National Foundation for Cancer Research
2:30pm - 3:20pm
Sealing the Deal: Powering Autoimmune Breakthroughs Through Strategic Investment & Partnerships
- Laura Tadvalkar - Managing Director, RA Capital
- Saifur Rahman - Senior Director Business Development & Licensing, Sanofi
- John Mayfield - SVP, Business Development & Strategy, Flagship Pioneering
- Paul Oppold - VP, Investments & Head of Coporate Development, Roivant Sciences
1:40pm - 2:30pm
New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025
- Mike Patten - Chief Strategy Officer, Harbour BioMed
- Michael Choi - Chief Business & Strategy Officer, CStone Pharmaceuticals
- Armin Rump - Associate Director, Global Business Development, Otsuka Pharmaceutical
- Osamu Nakanishi - President, Kissei America Inc.
2:30pm - 3:20pm
Talent for Tomorrow: How to Leverage a Hybrid Workforce for Innovation and Growth
- Erik Fink - Managing Partner & Co-CEO, Slone Partners
- Christine Horton - CEO, Visura Technologies
- Sam Windsor - CEO, Ignota Labs
1:40pm - 2:30pm
Concept to Commercialization: Best Practices for Growth and Scaling
- Darshana Zaveri - Managing Partner, Catalyst Health Ventures
- Amy Salzhauer - Founder & Managing Partner, Good Growth Capital
- Rich Yang - CEO, Biolinq
- Nishant Doctor - CEO, Surf Therapeutics
2:30pm - 3:20pm
Navigating FDA Approval: Streamlining Regulatory Approval and Unlocking Commercialization
- Julie Lankiewicz - Director, Global Clinical Strategy – Orthopaedics, Robotics and Digital Health/Enabling Technologies, Smith+Nephew
- Karen Kazak - Director, Regulatory Affairs and Quality Management, Intelerad
- Shri Raghunathan - CEO, Noctrix Health
- Trena Depel - VP, Clinical, Regulatory, Quality, Teal Health
1:40pm - 2:30pm
TechBio Meets Pharma: AI Powered Drug Discovery & Development
- Elena Diez Cecilia - Senior Director External Innovation DPDS, Johnson & Johnson
- Liz Schwarzbach - Chief Business Officer, BigHat Biosciences
- Petrina Kamya - Global Head of AI Platforms, VP, Insilico Medicine
- Chirag Sachar - Portfolio Innovation Director, Novartis
2:30pm - 3:20pm
Easing The Burden on Patients with Digital Tech – Intelligent Clinical Trials
- Gizem Demircioglu - Director, Digital Health Strategy, AstraZeneca
- Rob Freishtat - President & Co-Founder, Uncommon Cures
3:20pm - 3:50pm
Afternoon Break
Showing 3 of 3 Streams
Biotech Leaders Afternoon Keynote Plenary
Medtech Leaders
Pharmatech Leaders
3:50pm - 4:40pm
Biotech's Next Chapter: Innovating Smarter in a Changing Financial Landscape
- Elizabeth Bailey - Co-Founder & Managing Partner, Foreground Capital
- Kristian Werling - Global Head, Health and Life Sciences Practice Group, McDermott Will & Emery
- Luba Greenwood - Managing Partner, Binney Street Capital Venture Fund, Dana-Farber Cancer Institute
- Devin Rosenthal - Principal & Head of Due Diligence, NovaQuest Capital Management
- Greg Fralish - CBO, GlycoEra
- Bernard Cooney - Senior Partner, Flagship Pioneering
4:40pm - 5:30pm
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
- Scott DeWire - Corporate SVP, Head of Global BD&L, Boehringer Ingelheim
- Nicole Daley - Partner, A&O Shearman
- Konstantina Katcheves - SVP, Business Development, Alliance Management, & Acquisitions, Teva Pharmaceuticals
- Stu Mackey - Global Head of Business Development, Daiichi-Sankyo
- Issei Tsukamoto - SVP, Global Head Business Development, Astellas Pharma
3:50pm - 4:40pm
Venture Capital and Beyond: Exploring Diverse Funding Models for Medtech and Digital Health Innovation
- William Kidston - Partner & Chief Investment Officer, Kenston Capital Partners
- Alex de Winter - VP New Ventures, Danaher Ventures
4:40pm - 5:30pm
Great Expectations: Aligning with Investor Expectations and Communicating Value
- Jeff Chu - Co-founder & Managing Partner, Features Capital
- Vipul Kella - General Partner, 46 Venture Capital
- Karim ReFaey - Principal, DigitalDx Ventures
3:50pm - 4:40pm
AI, Data, and Precision Medicine: Opportunities, Challenges & Overcoming the Barries to Personalised Medicine
- Dishant Kalra - Head, Precision Medicine, Astellas Pharma
- Shameer Khader - Executive Director, Precision Medicine & Computational Biology, Sanofi
4:40pm - 5:30pm
A Unified Digital Front: Aligning Commercial and R&D Through Shared Technology
- Amir Zur - Executive Director, Regional Head of R&D Engineering, Digital Unit, Olympus Corporation
- Sarah Small - Director, Health Experience (HX) Development, Otsuka Precision Health
5:30pm - 5:35pm
Close of Day 1 Agenda – Followed by Networking Reception
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats